Implementation and Outcomes Research

This funding opportunity is now closed.

Program Overview

This grant opportunity is intended to support innovative investigators from companies, research institutions, and other eligible organizations to translate promising research and scientific discoveries into the development of tools, devices, technologies, therapeutics, or interventions related to cancer. This request for proposals (RFP) seeks applications that are focused on the development and implementation or translation of innovative ideas that have the potential to address important needs related to cancer prevention, screening, detection, treatment, and survivorship and that will ultimately advance cancer care, lessen the burden of cancer, and improve health outcomes.  

Proposed projects should be focused on implementing or translating research findings into a cancer-related product or technology or evaluating the outcomes of implementing scientific discoveries in cancer research. Projects may be anywhere along the implementation translational cancer research continuum, from proof-of-concept research to product launch and commercialization to implementation of an intervention. Projects should be additive to current understanding and seek to create new knowledge. Projects that include a provision of services that includes quantifiable outcomes data suitable for efficacy research are eligible.  

A portion of administrative costs for essential product development and commercialization activities may be allowed but only if they are not the primary focus of the project. Projects that primarily seek funding for advertisement and promotion for commercialization, without seeking to create knowledge, are not aligned with the program’s purpose. 

The total grant request (direct and indirect costs) over the project period may not exceed $1,500,000 and may not be less than $250,000*.

* This grant requires one-to-one (1:1) matching funds from a non-state of Washington source.